Log In
BCIQ
Print this Print this
 

AXL receptor tyrosine kinase (AXL) (UFO)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting AXL receptor tyrosine kinase (AXL) (UFO)

BCIQ
Print ChartPrint this
6 1 1
Phases of DevelopmentPreclinicalPhase IPhase I/II
Cancer

6

1

1




 Products Targeting AXL receptor tyrosine kinase (AXL) (UFO)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$222.3M

$11.0M

$200.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today